Activation of the Constitutive Androstane Receptor Inhibits Leukocyte Adhesiveness to Dysfunctional Endothelium

Autor: Maria-Jesus Sanz, Mireia López-Riera, Luisa Hueso, María Carmen Montesinos, Rebeca Ortega, Laura Piqueras, Mari Carmen Gomez-Cabrera, José T. Real
Rok vydání: 2021
Předmět:
Male
Small interfering RNA
Endothelium
QH301-705.5
Receptors
Cytoplasmic and Nuclear

Vascular Cell Adhesion Molecule-1
Leukocyte Rolling
Retinoid X receptor
Article
endothelial dysfunction
Catalysis
Inorganic Chemistry
Mice
Constitutive androstane receptor
Cell Adhesion
Human Umbilical Vein Endothelial Cells
Leukocytes
medicine
Animals
Humans
Biology (General)
Physical and Theoretical Chemistry
Endothelial dysfunction
QD1-999
Molecular Biology
Spectroscopy
constitutive androstane receptor
Tumor Necrosis Factor-alpha
Chemistry
Organic Chemistry
NF-kappa B
Endothelial Cells
leukocyte recruitment
General Medicine
medicine.disease
Computer Science Applications
Cell biology
medicine.anatomical_structure
Gene Expression Regulation
Tumor necrosis factor alpha
Intravital microscopy
Signal Transduction
Zdroj: International Journal of Molecular Sciences
Volume 22
Issue 17
International Journal of Molecular Sciences, Vol 22, Iss 9267, p 9267 (2021)
ISSN: 1422-0067
DOI: 10.3390/ijms22179267
Popis: Leukocyte cell recruitment into the vascular subendothelium constitutes an early event in the atherogenic process. As the effect of the constitutive androstane receptor (CAR) on leukocyte recruitment and endothelial dysfunction is poorly understood, this study investigated whether the role of CAR activation can affect this response and the underlying mechanisms involved. Under physiological flow conditions, TNFα-induced endothelial adhesion of human leukocyte cells was concentration-dependently inhibited by preincubation of human umbilical arterial endothelial cells with the selective human CAR ligand CITCO. CAR agonism also prevented TNFα induced VCAM-1 expression, as well as MCP-1/CCL-2 and RANTES/CCL-5 release in endothelial cells. Suppression of CAR expression with a small interfering RNA abrogated the inhibitory effects of CITCO on these responses. Furthermore, CITCO increased interaction of CAR with Retinoid X Receptor (RXR) and reduced TNFα-induced p38-MAPK/NF-κB activation. In vivo, using intravital microscopy in the mouse cremasteric microcirculation treatment with the selective mouse CAR ligand TCPOBOP inhibited TNFα-induced leukocyte rolling flux, adhesion, and emigration and decreased VCAM-1 in endothelium. These results reveal that CAR agonists can inhibit the initial inflammatory response that precedes the atherogenic process by targeting different steps in the leukocyte recruitment cascade. Therefore, CAR agonists may constitute a new therapeutic tool in controlling cardiovascular disease-associated inflammatory processes.
Databáze: OpenAIRE